data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Monte Rosa Therapeutics
(NASDAQ:GLUE)
$10.11
0.44[4.55%]
At close: Jul 1
$10.11
00
After Hours: 4:31PM EDT
Day High/Low9.69 - 10.2
52 Week High/Low6.05 - 45.56
Open / Close9.77 / 10.11
Float / Outstanding17.4M / 46.7M
Vol / Avg.64.3K / 205.4K
Mkt Cap471.8M
P/E-
50d Avg. Price9.07
Div / Yield-
Payout Ratio-
EPS-0.51
Total Float17.4M

Monte Rosa Therapeutics (NASDAQ:GLUE), Quotes and News Summary

Monte Rosa Therapeutics (NASDAQ: GLUE)

Day High/Low9.69 - 10.2
52 Week High/Low6.05 - 45.56
Open / Close9.77 / 10.11
Float / Outstanding17.4M / 46.7M
Vol / Avg.64.3K / 205.4K
Mkt Cap471.8M
P/E-
50d Avg. Price9.07
Div / Yield-
Payout Ratio-
EPS-0.51
Total Float17.4M
Benzinga - Jun 17, 2022, 3:38AM
Benzinga - May 12, 2022, 7:05AM
Benzinga - May 11, 2022, 7:33AM
Benzinga - Apr 28, 2022, 6:13AM
Benzinga - Apr 26, 2022, 9:37AM
Benzinga - Mar 29, 2022, 7:33AM
Benzinga - Feb 10, 2022, 4:51AM
Benzinga - Jan 25, 2022, 7:35AM
Benzinga - Nov 10, 2021, 7:50AM
Benzinga - Oct 20, 2021, 7:38AM
Benzinga - Oct 14, 2021, 7:36AM
Benzinga - Sponsored
Benzinga - Sep 30, 2021, 4:31PM
Benzinga - Sep 10, 2021, 7:34AM
load more
Sector: Health Care.Industry: Biotechnology
Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enables to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.510
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Monte Rosa Therapeutics Questions & Answers

Q
How do I buy Monte Rosa Therapeutics (GLUE) stock?
A

You can purchase shares of Monte Rosa Therapeutics (NASDAQ: GLUE) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Monte Rosa Therapeutics's (GLUE) competitors?
Q
What is the target price for Monte Rosa Therapeutics (GLUE) stock?
A

The latest price target for Monte Rosa Therapeutics (NASDAQ: GLUE) was reported by Piper Sandler on Thursday, May 12, 2022. The analyst firm set a price target for 21.00 expecting GLUE to rise to within 12 months (a possible 107.72% upside). 7 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Monte Rosa Therapeutics (GLUE)?
A

The stock price for Monte Rosa Therapeutics (NASDAQ: GLUE) is $10.11 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Monte Rosa Therapeutics (GLUE) pay a dividend?
A

There are no upcoming dividends for Monte Rosa Therapeutics.

Q
When is Monte Rosa Therapeutics (NASDAQ:GLUE) reporting earnings?
A

Monte Rosa Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Monte Rosa Therapeutics (GLUE) going to split?
A

There is no upcoming split for Monte Rosa Therapeutics.

Q
What sector and industry does Monte Rosa Therapeutics (GLUE) operate in?
A

Monte Rosa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.